Page last updated: 2024-08-26

betamethasone 21-valerate and Psoriasis

betamethasone 21-valerate has been researched along with Psoriasis in 1 studies

*Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abeni, D; Alessandroni, L; Di Pietro, C; Didona, B; Gisondi, P; Rota, L; Sampogna, F; Tabolli, S1

Trials

1 trial(s) available for betamethasone 21-valerate and Psoriasis

ArticleYear
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:3

    Topics: Adult; Betamethasone; Drug Administration Schedule; Eosine Yellowish-(YS); Female; Glucocorticoids; Humans; Keratolytic Agents; Male; Middle Aged; Patient Satisfaction; Psoriasis; Severity of Illness Index; Treatment Outcome

2009